Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

Q17_CONGEN_MALFO_SYNDR_KNOWN_EXOGE_CAUSES_NOT_ELSEW_CLASSIFIED

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Q86 Cause of death: ICD-10 — Q86 2 out of 7 registries used, show all original rules.	53
4. Check minimum number of events None	53
5. Include endpoints None	53
6. Filter based on genotype QC (FinnGen only)	42

Control definitions (FinnGen only)

Control exclude: Q17_OTHER_CONGEN_MALFO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Q8
Name in latin: Syndromata malformationum congenitarum e causis externis notis non alibi classificata

NAME	Q17_CONGEN_MALFO_SYNDR_KNOWN_EXOGE_CAUSES_NOT_ELSEW_CLASSIFIED
CONTROL_EXCLUDE	Q17_OTHER_CONGEN_MALFO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q86
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q86
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Congenital malformation syndromes due to known exogenous causes, not elsewhere classified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Fetal alcohol syndrome (dysmorphic)

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1153	503	650
Only index persons	998	447	551
Unadjusted period prevalence (%)
Whole population	0.02	0.01	0.02
Only index persons	0.02	0.02	0.02
Median age at first event (years)
Whole population	-	6.49	7.16
Only index persons	7.22	6.84	7.54

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	42	23	19
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	18.00	14.33	22.44

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6.78

9.37

3.7

2.2

0.98

1.08

e6/l

0.06

(3018418) pH of Serum or Plasma

6.42

9.35

4.8

4.6

7.39

0.29

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5.33

6.69

3.9

2.3

3.82

7.38

e6/l

—

(3030467) Casts [#/volume] in Urine by Automated count

4.41

5.90

4.5

2.3

0.23

0.31

e6/l

0.21

(3023368) Bacteria identified in Blood by Culture

3.94

4.72

5.9

3.4

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

115

3.51

4.30

8.3

2.7

—

(3018095) Leukocytes [#/volume] in Urine

139

3.51

4.25

5.1

3.0

46.34

32.69

e6/l

0.24

(36304419) Bacteria [Presence] in Urine

3.51

4.15

3.4

2.4

—

estimate

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

166

3.55

4.14

11.4

5.5

9.60

11.36

umol/l

0.69

156

(3014007) Fractional oxyhemoglobin in Arterial blood

7.16

3.67

29.3

5.2

94.26

95.22

—

(3042936) Bacteria identified in Isolate by Culture

4.52

3.62

2.2

1.7

—

(3024354) Oxygen [Partial pressure] in Venous blood

4.46

3.36

6.5

2.4

5.35

5.04

kpa

0.22

(3002173) Hemoglobin [Mass/volume] in Arterial blood

6.18

3.35

26.5

4.9

123.63

125.00

g/l

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

4.79

3.32

29.2

5.4

99.00

105.00

mmol/l

—

(4024509) Urine culture

5.30

3.31

2.3

1.8

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

6.11

2.99

33.1

5.2

1.61

1.25

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

6.11

2.99

33.1

5.2

0.60

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

6.11

2.99

4.0

2.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

7.44

2.96

22.8

3.0

17.20

17.28

—

(3016502) Oxygen saturation in Arterial blood

4.84

2.82

29.9

4.2

96.45

96.69

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

116

2.69

2.71

12.2

4.5

33.48

37.74

g/l

2.14

110

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

6.07

2.63

27.7

5.3

23.33

23.15

mmol/l

—

(3000991) Gas panel - Venous blood

3.69

2.63

24.5

4.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

4.37

2.60

16.3

6.4

23.74

24.78

mmol/l

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

5.55

2.48

1.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3.72

2.46

2.9

2.4

25.72

23.56

mmol/l

—

(3013512) EKG study

2.62

2.42

2.6

2.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3.97

2.39

29.9

3.9

5.14

5.05

kpa

—

(3027801) Oxygen [Partial pressure] in Arterial blood

3.97

2.39

29.9

3.9

10.86

15.11

kpa

—

(3033658) Prothrombin time (PT) actual/Normal

2.64

2.39

4.8

2.4

81.41

95.48

1.51

(40761535) Cells panel - Urine sediment

4.37

2.35

6.6

3.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3.80

2.30

1.8

1.7

—

(3022313) Gas panel - Capillary blood

4.14

2.25

4.3

8.4

—

(3026008) Bacteria identified in Urine by Culture

101

2.48

2.23

4.1

2.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2.48

2.18

3.3

2.5

50.22

56.43

u/l

1.06

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3.23

2.14

2.4

2.2

450.89

404.22

nmol/l

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

4.13

2.00

1.3

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

4.94

1.99

11.8

3.3

134.40

129.36

g/l

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

4.94

1.99

11.8

3.4

0.64

0.68

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2.75

1.95

2.4

2.2

55.00

344.14

ng/l

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

235

2.36

1.90

14.3

8.5

4.31

3.61

e9/l

1.15

205

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

4.52

1.87

11.8

3.2

2.06

1.70

—

(3001604) Monocytes [#/volume] in Blood

207

2.24

1.84

9.7

5.7

0.64

0.54

e9/l

1.37

188

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.00

1.83

0.0

1.8

—

3.68

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3.66

1.81

2.7

1.1

—

(3006315) Basophils [#/volume] in Blood

208

2.22

1.80

9.7

5.7

0.05

0.04

e9/l

1.41

188

(3021589) Normoblasts [#/volume] in Blood

189

2.19

1.80

13.9

7.5

0.00

e9/l

-0.00

152

(3019198) Lymphocytes [#/volume] in Blood

214

2.11

1.60

9.7

5.6

1.96

2.05

e9/l

0.23

199

(40758558) Short blood count panel - Blood

123

2.09

1.58

13.8

5.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2.23

1.55

2.1

1.6

1.49

1.38

0.36

(1761868) Lipid panel - Serum or Plasma

154

0.42

1.51

4.1

2.5

—

(42870588) Differential panel, method unspecified - Blood

127

2.00

1.43

8.2

5.5

—

(3013115) Eosinophils [#/volume] in Blood

220

2.01

1.42

10.5

5.6

0.24

0.19

e9/l

0.45

201

(3025941) Bacteria identified in Stool by Culture

2.84

1.41

1.5

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.31

1.41

2.5

1.9

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

0.00

1.40

0.0

1.7

—

3.58

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.35

1.40

1.3

—

(3015736) pH of Urine

173

1.95

1.39

5.7

2.8

6.27

6.18

0.12

100

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.54

1.35

2.4

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.40

1.29

2.3

1.4

—

(3002256) Pathology report gross observation

0.00

1.21

0.0

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1.85

1.03

4.7

2.7

29.31

18.77

ng/l

—

(3021601) Nitrite [Presence] in Urine by Test strip

205

1.75

1.02

6.7

3.2

0.00

estimate

—

(3044640) Blood type and Crossmatch panel - Blood

114

1.77

0.97

3.5

1.9

—

(3028707) Methadone [Presence] in Urine by Screen method

2.31

0.95

1.5

1.6

—

(3000494) Fungus identified in Specimen by Culture

2.22

0.93

1.2

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

209

1.69

0.92

6.7

3.2

0.00

estimate

—

(40768804) Tissue Pathology biopsy report

133

0.52

0.91

2.4

2.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2.14

0.90

1.8

2.2

9.83

10.44

g/l

—

(3009261) Glucose [Presence] in Urine by Test strip

210

1.67

0.89

6.7

3.3

0.00

estimate

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

154

1.66

0.86

1.8

2.6

—

(40768797) Stomach Pathology biopsy report

1.84

0.86

1.3

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.90

0.82

1.2

1.7

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

105

1.63

0.71

2.5

2.8

2.32

2.35

mmol/l

0.68

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

133

1.57

0.69

1.7

1.6

82.86

95.88

pmol/l

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

161

1.55

0.69

6.9

2.9

0.00

0.03

estimate

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.00

0.61

0.0

1.6

—

3.63

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.57

0.60

1.3

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

0.00

0.60

0.0

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.57

0.54

1.5

2.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1.53

0.51

3.4

2.0

—

(3011288) Drugs identified in Urine by Screen method Nominal

1.50

0.48

2.0

1.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

171

1.41

0.48

5.1

2.5

—

estimate

—

(3029937) Albumin [Presence] in Urine by Test strip

106

1.46

0.46

7.1

3.6

0.00

estimate

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

347

1.50

0.42

29.2

12.2

13.70

13.26

1.08

341

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.42

0.0

1.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

0.00

0.42

0.0

1.3

—

35.88

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.42

0.0

1.0

—

1.51

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.42

0.0

1.0

—

0.93

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.00

0.42

0.0

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.53

0.42

1.0

—

(40761536) Microorganisms panel - Urine sediment

1.53

0.42

3.0

2.9

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1.43

0.39

2.6

2.0

14.88

12.58

nmol/l

—

(3003694) ABO and Rh group [Type] in Blood

141

1.32

0.32

1.5

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

337

0.76

0.29

3.2

3.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

117

1.28

0.24

1.5

2.01

2.06

g/l

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.21

0.0

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.21

0.0

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.29

0.21

1.8

1.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

0.00

0.21

0.0

1.2

—

333.60

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.18

0.20

1.7

1.3

—

(3016879) Cocaine [Presence] in Urine

1.24

0.19

1.6

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

1.15

0.18

1.6

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

0.77

0.17

2.2

2.8

118.12

107.65

ug/g

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

190

1.19

0.17

2.8

3.1

43.10

67.17

ug/l

1.43

184

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

343

1.21

0.14

5.8

4.2

2.61

2.78

mmol/l

0.57

325

(36660697) Celiac disease serology panel - Serum

1.15

0.10

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

1.13

0.08

1.6

1.4

—

(3027008) Opiates [Presence] in Urine

1.13

0.08

1.6

1.4

—

(3027944) Amphetamines [Presence] in Urine

1.13

0.08

1.6

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.10

0.08

2.3

2.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.85

0.07

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

129

1.12

0.06

1.8

—

(3019832) Treponema pallidum Ab [Presence] in Serum

119

1.01

0.00

1.4

1.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

124

0.96

0.00

7.0

2.6

0.00

estimate

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

134

0.96

0.00

2.6

2.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

128

1.02

0.00

2.4

2.6

—

(40768793) Breast Pathology biopsy report

0.00

0.0

1.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.0

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

0.00

0.0

1.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.0

3.7

—

22.00

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.6

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.1

—

111.43

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.0

1.3

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

0.0

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.0

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.00

-0.00

0.0

1.0

—

12.80

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

-0.00

0.0

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(21494434) Karyotype in Bone marrow

0.00

-0.00

0.0

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

29.58

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.8

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3049717) Cytology report of Urine Cyto stain

0.00

-0.00

0.0

1.6

—

(40760892) CBC W Ordered Manual Differential panel - Blood

0.89

-0.00

9.5

6.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

-0.00

0.0

1.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

130

1.00

-0.00

2.1

2.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(40761511) CBC panel - Blood by Automated count

403

1.14

-0.00

26.4

8.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.98

-0.00

2.7

2.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1.00

-0.00

1.2

2.2

2.39

2.41

mmol/l

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

-0.00

0.0

1.8

—

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_CONGEN_MALFO_SYNDR_KNOWN_EXOGE_CAUSES_NOT_ELSEW_CLASSIFIED and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have Q17_CONGEN_MALFO_SYNDR_KNOWN_EXOGE_CAUSES_NOT_ELSEW_CLASSIFIED.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: Q17_CONGEN_MALFO_SYNDR_KNOWN_EXOGE_CAUSES_NOT_ELSEW_CLASSIFIED – Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints